John Maraganore - 10 Jun 2026 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Reporting relationship: Director
Issuer ticker: RAPP
Reported as of: 10 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 17:57:24 UTC
Prior SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Troy Ignelzi, Attorney-in-Fact

Key filing fact

John Maraganore filed Form 4 for Rapport Therapeutics, Inc. (RAPP) on 10 Jun 2026.

Key facts

This page summarizes John Maraganore's Form 4 filing for Rapport Therapeutics, Inc. (RAPP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 17:57.

Change

Previous filing in this sequence was filed on 05 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001180432 Primary reporting owner

MARAGANORE JOHN

Relationship: Director
Address: RAPPORT THERAPEUTICS, INC., 99 HIGH STREET, SUITE 2100, BOSTON
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Signature date: 10 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RAPP transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +15,200
Change %
Price: $0.000000^*
Shares after: 15,200
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,200
Exercise price: $35.21
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.